Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedaquiline Monotherapy for Multibacillary Leprosy
NCT03384641Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bedaquiline in leprosy (HD), sponsored by Janssen Pharmaceutical. Started Sep 2018; status: completed.
02
Drugs
bedaquiline
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on NCT03384641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384641.